COMPANY PROFILE // THE 014 REPORT

Theravance Biopharma, Inc.

Assembled from 2 government sources in 0.2 s

Built from public records at 2026-11-21 22:14 ET. Every figure links to its source. Flags and checks built 2026-11-21 22:14 ET. Sources

FLAGS · DISCLOSURE · SUMMARY

Missing or hidden

  • Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-09-23 (last 24 months).2026-09-23 · source

✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration

No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.

Theravance Biopharma, Inc. is an SEC-registered operating company in pharmaceutical preparations, incorporated in CA, based in George Town, Grand Cayman, CA.[source] It reported revenue of $107.5 million for the fiscal year ended 2025-12-31.[source] It has filed 94 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-11-16.[source] Its largest institutional holders on 13F filings are Madison Avenue Partners, LP, Weiss Asset Management LP, BlackRock, Inc. (as of 2026-06-30).[source] Seraphix flags 1 item from these records: 8-K Item 3.01 filed.[source]

0federal award recipients matched by name in USAspending
0lobbying filings name it as client
94SEC filings in the last 12 months
$579.0Mheld by its 10 largest 13F holders (as of 2026-06-30)
SEC filings by month, 24 months
2024-12: 02025-01: 22025-02: 72025-03: 62025-04: 32025-05: 152025-06: 72025-07: 22025-08: 92025-09: 02025-10: 02025-11: 112025-12: 42026-01: 12026-02: 62026-03: 72026-04: 52026-05: 72026-06: 122026-07: 22026-08: 132026-09: 282026-10: 12026-11: 32024-122026-11
Flags by level
  • red0
  • amber1
  • info0
Largest 13F holders, value as filed
  • Madison Avenue Partners, LP$156.6M
  • Weiss Asset Management LP$126.8M
  • BlackRock, Inc.$77.6M
  • Newtyn Management, LLC$58.4M
  • Irenic Capital Management LP$46.9M
  • VANGUARD CAPITAL MANAGEMENT LLC$30.1M
  • STATE STREET CORP$22.6M
  • TWO SIGMA INVESTMENTS, LP$20.8M

RECORD · WEB

Ask about this entity

Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).

EVERY LIST AND SOURCE · DATED

Checked and clear

26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.

EVERY IDENTIFIER · LINKED

ID crosswalk

IdentifierValueRecord
SEC CIK0001583107source
EIN00-0000000source
Business address (SEC)UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN, CA, KY1-1104source

Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.

EACH FEEDS WATCH

Dates coming up

PEERS BY SIC CODE

Industry context

SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.

Peers, each with its 014

  • PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
  • Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
  • ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
  • ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
  • TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
  • NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
  • Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
  • Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
  • SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
  • Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
  • UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
  • Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)

EVERY SOURCE · NEWEST FIRST

One timeline

125 earlier entries

RENDERED FROM THIS PAGE

Relationship graph

Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.

DATA MOTION // NEWEST FIRST

What changed

Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.

COUNTS FROM THIS PAGE

Relationships at a glance

10largest institutional holders (13F as filed)
0other entities in the GLEIF ownership tree (ID tier)
0awarding federal agencies
0hiring lobbying firms: possible match: matched by name only, not merged
PRICE · FILINGS · POSTS · NEWS

Market & news

Price
No listing symbol is held for this company.
Open in
Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

Financials
Filed figures: published SEC values, each linked to its filing.
Official posts
Links to posts from the company's and agencies' verified accounts: not connected yet.
News
Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER

1. Identity

0confirmed members (SEC registrant + GLEIF ownership tree)
0legal entities (LEI) in the ownership tree
25dated filings and events

0 possible matches held apart, matched by name only, not counted above.

IdentifierValueHow it was resolvedSource
SEC CIK1583107id:sec-anchor: the SEC registrant record of this companySEC EDGAR
CUSIPG8807B106carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001583107SEC EDGAR

The company table did not answer, so only the identifiers carried on the SEC record are shown.

Next: reload in a minute, or open the record page.

AS FILED · EACH WITH ITS DATE AND FILING

2. Filed figures

Key figures (annual filing)

FigureValuePeriod or as ofSourceBasisRetrievedReport
Revenue (fiscal year ended 2025-12-31)$107,464,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTaxas filed2026-11-22 03:14 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$105,895,0002025-12-3110-K, XBRL NetIncomeLossas filed2026-11-22 03:14 UTCReport an error
Total assets (at 2025-12-31)$485,570,0002025-12-3110-K, XBRL Assetsas filed2026-11-22 03:14 UTCReport an error
Stockholders' equity (at 2025-12-31)$296,723,0002025-12-3110-K, XBRL StockholdersEquityas filed2026-11-22 03:14 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$167,806,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValueas filed2026-11-22 03:14 UTCReport an error

Company profile facts (SEC)

FigureValuePeriod or as ofSourceBasisRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profileas filed2026-11-22 03:14 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-16SEC EDGAR company profileas filed2026-11-22 03:14 UTCReport an error
State of incorporationCA2026-11-16SEC EDGAR company profileas filed2026-11-22 03:14 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profileas filed2026-11-22 03:14 UTCReport an error
Business addressUGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN, CA, KY1-11042026-11-16SEC EDGAR company profileas filed2026-11-22 03:14 UTCReport an error

Other filed values

FigureValuePeriod or as ofSourceBasisRetrievedReport
Operating cash flow (fiscal year ended 2025-12-31)$238,541,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivitiesas filed2026-11-22 03:14 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$42,0002025-12-3110-K, XBRL PaymentsToAcquireProductiveAssetsas filed2026-11-22 03:14 UTCReport an error
Operating lease liabilities (at 2025-12-31)$42,703,0002025-12-3110-K, XBRL OperatingLeaseLiabilityas filed2026-11-22 03:14 UTCReport an error

Latest report: 10-Q for the period ended 2026-06-30, filed 2026-08-11 · accession 0001104659-26-093773

ItemValuePeriodFormFiledAccessionRetrievedReport
Revenue$20,731,0003 months ended 2026-06-3010-Q2026-08-110001104659-26-0937732026-11-22 03:14 UTCReport an error
Net income (loss)-$5,898,0003 months ended 2026-06-3010-Q2026-08-110001104659-26-0937732026-11-22 03:14 UTCReport an error
Cash and cash equivalents$219,766,000at 2026-06-3010-Q2026-08-110001104659-26-0937732026-11-22 03:14 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.

No estimates: every value is as filed and links to the filing it came from.

Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.

NEWEST FIRST · EACH LINKS TO ITS FILING

3. Registration and filing timeline

8-K item text, as filed (excerpts)

Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.

AS FILED · LARGEST HOLDERS

10. 13F institutional holders

RankHolder (13F filer)Value heldAs ofSourceRetrievedReport
1Madison Avenue Partners, LP$156,608,2842026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error
2Weiss Asset Management LP$126,770,0202026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error
3BlackRock, Inc.$77,562,2792026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error
4Newtyn Management, LLC$58,381,2472026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error
5Irenic Capital Management LP$46,936,1162026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error
6VANGUARD CAPITAL MANAGEMENT LLC$30,115,3812026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error
7STATE STREET CORP$22,585,9282026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error
8TWO SIGMA INVESTMENTS, LP$20,834,9792026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error
9D. E. Shaw & Co., Inc.$20,151,6302026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error
10GEODE CAPITAL MANAGEMENT, LLC$19,006,1982026-06-30SEC 13F filing2026-11-22 03:14 UTCReport an error

13F as filed: the holder's own report of its position value at the quarter end.

WHAT THIS PAGE READ

Sources

As of 2026-11-22 (record built 2026-11-22T03:14:39Z). Sources used: SEC EDGAR, SEC 13F holdings.

Not checked: FTC enforcement actions; DOJ press releases (beyond FARA and the corporate enforcement set); federal and state court records; UCC filings, liens and bankruptcy dockets; IRS automatic revocation list; state annual-report dates; company formation dates (only where a state registry record states one).

JSON · MCP · API

API and agents

The same profile as JSON: GET /company/1583107.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001583107. Every source URL used is listed in the file.

Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.